[Modern pharmacological therapy of breast cancer]
- PMID: 22217685
- DOI: 10.1556/OH.2012.29257
[Modern pharmacological therapy of breast cancer]
Abstract
Healthy lifestyle, population-based screening mammography and modern medical-oncological treatment in specialized breast cancer centers are the basic elements of the fight against breast cancer mortality. Treatment plan for the individual patient should be recommended by multidisciplinary oncoteam before initiating definitive therapy. Strategy of the medical-oncological therapy of breast cancer is determined by the biological features and stage of the tumor. The most important biological features are endocrine sensitivity, Human Epidermal Growth Factor Receptor 2 status and proliferative capability of the tumor. In this review the strategy of medical-oncological treatment (chemotherapy, endocrine therapy, targeted biological therapy) of breast cancer is presented, based on receptor status and proliferative capability of the tumor in various stages of the disease.
Similar articles
-
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.Cancer Treat Rev. 2015 Feb;41(2):94-104. doi: 10.1016/j.ctrv.2014.12.011. Epub 2014 Dec 30. Cancer Treat Rev. 2015. PMID: 25575443 Review.
-
[Pharmaceutical therapy of breast cancer].Magy Onkol. 2010 Sep;54(3):237-54. doi: 10.1556/MOnkol.54.2010.3.5. Magy Onkol. 2010. PMID: 20870601 Hungarian. No abstract available.
-
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.J Clin Oncol. 2016 Apr 1;34(10):1065-71. doi: 10.1200/JCO.2015.62.8503. Epub 2015 Nov 23. J Clin Oncol. 2016. PMID: 26598746
-
Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system.J Clin Oncol. 2014 Jul 10;32(20):2151-8. doi: 10.1200/JCO.2013.52.0858. Epub 2014 Jun 2. J Clin Oncol. 2014. PMID: 24888815
-
[Adjuvant chemotherapy of early stage breast cancer].Orv Hetil. 2010 Feb 28;151(9):344-53. doi: 10.1556/OH.2010.28824. Orv Hetil. 2010. PMID: 20159750 Review. Hungarian.
Cited by
-
Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma.Springerplus. 2015 Jul 31;4:387. doi: 10.1186/s40064-015-1171-8. eCollection 2015. Springerplus. 2015. PMID: 26240785 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials